Restricted accessResearch articleFirst published online 2010-12
Neutrophil Elastase Inhibitor Restores Gut Ischemia Reperfusion-Induced Impairment of Gut Immunity with Reduced Plasma Interleukin-6 Concentrations in Mice
: Gut-associated lymphoid tissue (GALT) is regarded as central mucosa-associated lymphoid tissue that influences systemic mucosal immunity. Our previous study revealed that gut ischemia and reperfusion (I/R) reduces GALT lymphocyte numbers. Because gut hypoperfusion frequently occurs in trauma, shock, and surgery patients, establishment of a therapeutic method to preserve GALT mass after gut I/R may be important for the prevention of infections. We examined the effects of sivelestat sodium hydrate, a selective inhibitor of neutrophil elastase, on GALT mass and plasma cytokine concentrations in a murine gut I/R model.
Methods
: Seventy male ICR mice were randomized to the control (n = 34) or the sivelestat (n = 36) group. After intravenous cannulation of the animals, the superior mesenteric artery was occluded for 60 min. After reperfusion, physiologic saline or sivelestat 5 mg/kg hourly was infused for 24 h. Sixteen mice in the control and 22 in the sivelestat group were alive at 24 h. Twenty-six mice (n = 13 in each group) were chosen randomly for harvest of the small intestine. Lymphocytes from Peyer patches (PP), the intraepithelial space (IE), and the lamina propria (LP) were counted; and their phenotypes (αβT-cell receptor (TCR), γδTCR, CD4, CD8, B cell) were determined by flow cytometry. Cytokine concentrations (interleukin [IL]-6, IL-1β, IL-10) in the plasma and bronchoalveolar lavage fluid were measured by enzyme-linked immunosorbent assay.
Results
: Sivelestat treatment did not improve survival but increased PP and IE lymphocyte numbers significantly and reduced the LP CD8+ cell percentage and plasma IL-6 concentration compared with controls. There were no significant differences between the two groups in other cell phenotypes or cytokine concentrations.
Conclusion
: Sivelestat treatment after gut I/R may be useful for maintaining gut immunity and preventing systemic inflammatory responses.
KudskKA. Current aspects of mucosal immunology and its influence by nutrition. Am J Surg, 2002; 183:390–398.
4.
ManhartN, VierlingerK, HabelOet al.Lipopolysaccharide causes atrophy of Peyer's patches and an increased expression of CD28 and B7 costimulatory ligands. Shock, 2000; 14:478–483.
5.
GryglewskiA, SzczepanikM, MajcherPet al.Different patterns of gamma delta and alpha beta T cell redistribution in the mouse after partial gastrectomy. J Surg Res, 1997; 73:137–142.
LiJ, KudskKA, GocinskiBet al.Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma, 1995; 39:44–51.
8.
OkamotoK, FukatsuK, UenoCet al.T lymphocyte numbers in human gut associated lymphoid tissue are reduced without enteral nutrition. JPEN J Parenter Enteral Nutr, 2005; 29:56–58.
9.
FukatsuK, SakamotoS, HaraEet al.Gut ischemia-reperfusion affects gut mucosal immunity: A possible mechanism for infectious complications after severe surgical insults. Crit Care Med, 2006; 34:182–187.
10.
HassounHT, KoneBC, MercerDWet al.Post-injury multiple organ failure: The role of the gut. Shock, 2001; 15:1–10.
11.
MooreEE, MooreFA, FrancioseRJet al.The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma, 1994; 37:881–887.
12.
CardenD, XiaoF, MoakCet al.Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol, 1998; 275:H385–392.
13.
GuoL, YamaguchiY, IkeiSet al.Neutrophil elastase inhibitor (ONO-5046) prevents lung hemorrhage induced by lipopolysaccharide in rat model of cerulein pancreatitis. Dig Dis Sci, 1995; 40:2177–2183.
14.
KawabataK, HagioT, MatsumotoSet al.Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med, 2000; 161:2013–2018.
15.
InoueY, SeiyamaA, TanakaHet al.Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation. Crit Care Med, 2005; 33:1814–1822.
IbaT, KidokoroA, FukunagaMet al.Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock, 2006; 26:95–98.
HagaY, OgawaM. Neutrophil elastase inhibitor (ONO-5046.Na) decreases production of proinflammatory cytokines by lipopolysaccharide-stimulated human monocytes. Res Commun Mol Pathol Pharmacol, 1997; 98:243–248.
MythenMG, PurdyG, MackieIJet al.Postoperative multiple organ dysfunction syndrome associated with gut mucosal hypoperfusion, increased neutrophil degranulation and C1-esterase inhibitor depletion. Br J Anaesth, 1993; 71:858–863.
22.
SimpsonR, AlonR, KobzikLet al.Neutrophil and nonneutrophil-mediated injury in intestinal ischemia–reperfusion. Ann Surg, 1993; 218:444–453.
23.
HermsenJL, SanoY, GomezFEet al.Parenteral nutrition inhibits tumor necrosis factor-alpha-mediated IgA response to injury. Surg Infect, 2008; 9:33–40.
24.
NakamuraN, MorisakiH, SuzukiTet al.Inhibition of neutrophil elastase attenuates gut mucosal injury evoked by acute alveolar hypoxia in rabbits. Shock, 2007; 28:101–105.
25.
YanagiharaK, FukudaY, SekiMet al.Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia. Exp Lung Res, 2007; 33:71–80.
